Maxygen, Inc. (MAXY) To Receive $17.8 Million From Acquisition Of Avidia, Inc. By Amgen (AMGN)
10/27/2006 5:38:11 PM
More...
|
Amgen (AMGN) Completes Acquisition Of Avidia, Inc.
10/25/2006 11:58:56 AM
More...
|
The Day In Review: Amgen (AMGN) Buys Avidia, Inc. For $290 Million
10/3/2006 10:23:09 AM
More...
|
Amgen (AMGN) To Acquire Avidia, Inc., A Privately Held Biopharmaceutical Company In The San Francisco Bay Area; $290 Million Cash
9/29/2006 9:57:59 AM
More...
|
Avidia, Inc. Initiates Clinical Trial Of Novel Inhibitor Of Interleukin-6 For Crohn's Disease
9/20/2006 11:28:54 AM
More...
|
Avidia, Inc. Adds Dr. Jose-Carlos Gutierrez-Ramos To Its Management Team As Chief Scientific Officer
8/29/2006 1:28:25 PM
More...
|
Avidia, Inc. Expands Senior Management Team
6/27/2006 11:48:21 AM
More...
|
Avidia, Inc. Raises $43.8M Series C To Advance New Class Of Pharmaceuticals
5/9/2006 12:24:35 PM
More...
|
The Journal Nature Biotechnology Publishes An Article Describing Avidia, Inc.'s Avimer Technology
11/7/2005 1:01:57 PM
More...
|
MedImmune, Inc. (MEDI) Further Expands Oncology Pipeline With New Target Based On Innovative Technology From Avidia, Inc.
10/20/2005 2:37:31 PM
More...
|
|